全球兽医循环系统市场

预计到 2030 年，全球兽医循环系统市场美国将达到 42 亿美元

全球兽医循环系统市场规模预计在2024年达到27亿美元，预计2024年至2030年期间的复合年增长率为7.5%，到2030年将达到42亿美元。伴侣动物是本报告分析的细分市场之一，预计其复合年增长率为8.8%，到分析期结束时规模将达到28亿美元。生产性动物细分市场在分析期间的复合年增长率预计为5.0%。

美国市场规模估计为 7.374 亿美元，而中国市场预计复合年增长率为 11.9%

美国兽医循环系统市场规模预计在2024年达到7.374亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到8.936亿美元，在2024-2030年的分析期间内，复合年增长率为11.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.6%和7.3%。在欧洲，预计德国市场的复合年增长率为4.9%。

全球兽医循环系统市场—主要趋势和驱动因素摘要

为什么兽医循环系统成为伴侣动物医疗保健的支柱？

随着伴侣动物心臟相关疾病的发生率不断上升，以及宠物饲主对早期诊断和持续心臟护理重要性的认识不断提高，兽医循环系统正逐渐成为动物保健领域的重要专业。随着营养改善、预防保健和先进医疗手段的运用，宠物寿命不断延长，与老龄化相关的心血管疾病（如郁血性心臟衰竭衰竭、心律不整、瓣膜疾病和先天性畸形）也变得越来越常见。骑士查理王猎犬、拳师犬和杜宾犬等犬种以及某些猫种，在遗传上易患心臟病，需要接受专门治疗。兽医心臟科医生和全科医生都发现，越来越多的动物病例需要进行诊断检测，包括超音波心动图、心电图 (ECG)、X 射线成像和心臟生物标记检测。随着宠物饲主越来越多地将他们的动物视为家庭成员，他们更愿意寻求先进的诊断和治疗性介入，以提高生活品质并延长寿命。对动物健康和专科护理的日益重视，导致世界各地的都市区诊所、专科医院和学术动物医院对兽医循环系统服务的需求大幅增加。

诊断和影像方面的创新如何改善动物的心臟照护？

技术创新正在改变兽医循环系统，使动物心血管疾病的早期发现、更准确的诊断和更好的监测成为可能。最新的超音波心动图设备现在提供专为兽医用途定制的高解析度多普勒影像，使临床医生能够高精度地评估血流、瓣膜功能和心室大小。可携式无线网路系统促进了护理点和家庭心率分析，改善了全科诊所和行动服务中诊断服务的可及性。 NT-proBNP 和肌钙蛋白等心臟生物标记越来越多地被用于筛检、分期和监测心臟疾病，为诊断成像提供了微创补充。 3D 超音波心动图、电脑断层扫描 (CT) 和磁振造影(MRI) 等先进影像工具在兽医转诊中心越来越普遍，尤其是对于复杂病例。远端医疗在兽医循环系统领域也发挥着越来越重要的作用，使执业医师能够远距咨询专家，并快速解读心电图和超音波心动图结果。这些技术发展简化了工作流程，提高了临床准确性，最终有助于更有效地管理兽医心臟病患者，改善其治疗效果。

为什么兽医和专科医院要扩大心臟病学服务？

兽医院、专科医院和学术中心正在加大心臟病学服务的投资，以满足日益增长的专科护理需求，并为复杂病例提供全方位的综合护理。综合兽医院正在将听诊训练、掌上超音波设备和心电图等基本心臟筛检工具纳入身体检查和麻醉前筛检中，以帮助发现心臟疾病的早期迹象。转诊医院和专科医院则更进一步，设立了配备委员会认证专家和最先进诊断实验室的专门心臟科。这些中心不仅提供诊断，还透过长期药物治疗、心律调节器植入、液体管理通讯协定以及必要时的手术干预来治疗慢性心臟疾病。大学兽医学院正在加强心臟病学课程，扩大比较心臟病学、药物开发和先天性心臟疾病修復的研究。此外，与製药和医疗设备公司的合作正在推动针对小动物的新型治疗方法的开发。提供先进心臟护理的竞争诊所正在通过满足宠物医疗这一日益增长的领域而获得竞争优势，该领域受到宠物饲主的高度重视，并且通常需要后续访问、持续监测和个性化治疗计划，从而建立更牢固的客户关係并提高患者的终身价值。

推动兽医循环系统市场全球成长的因素是什么？

兽医循环系统市场的成长受到多种相互关联的因素驱动，包括宠物数量动态、技术进步、临床创新以及对高级动物护理日益增长的投资意愿。关键驱动因素是全球宠物拥有量的增加以及宠物人性化趋势的日益增长，这提高了人们对心臟病等慢性和与老龄化相关的疾病的认识。更准确、更实惠的诊断工具的出现使全科医生能够在疾病週期的早期对患者筛检并将其转诊进行专门的心臟评估。动物用药品的进步，特别是在血管紧张素转换酶 (ACE) 抑制剂、 β阻断剂、利尿剂和新型心臟药物领域的进步，使得对心臟病的长期管理更加有效。专科医疗设施和兽医循环系统培训计画的扩展有助于缩小专家就诊机会的差距，尤其是在都市区。此外，宠物保险的广泛普及使更多人能够以更经济的方式获得高级心臟护理。研究合作和临床试验也在加速药物开发和治疗通讯协定。这些因素共同作用，将兽医循环系统从小众专业转变为综合宠物医疗保健的主流领域，并对诊所的结构、兽医专业人员的培训以及宠物的护理方式产生越来越大的影响。

部分

动物类型（伴侣动物、生产动物）；产品（药品、诊断）；适应症（郁血性、心肌病变、心律不整、其他）；最终使用者（兽医院和诊所、其他）

受访公司范例

• ALBA Medical Systems, Inc.
• Antech Diagnostics
• Boehringer Ingelheim International
• Bionet America
• Ceva Sante Animale
• Cronus Pharma
• Dextronix
• Esaote SpA
• FUJIFILM Holdings Corporation
• General Electric Company
• IDEXX Laboratories
• IMV Technologies
• Infiniti Medical
• Jurox
• Medtronic
• Merck & Co., Inc.
• Patterson Veterinary
• Pet Cardiology
• RHC Medical
• Scapa Healthcare

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Veterinary Cardiology Market to Reach US$4.2 Billion by 2030

The global market for Veterinary Cardiology estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Companion Animals, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Production Animals segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$737.4 Million While China is Forecast to Grow at 11.9% CAGR

The Veterinary Cardiology market in the U.S. is estimated at US$737.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$893.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Veterinary Cardiology Market - Key Trends & Drivers Summarized

Why Is Veterinary Cardiology Becoming a Pillar of Companion Animal Healthcare?

Veterinary cardiology is emerging as a crucial specialty in animal healthcare, driven by the increasing prevalence of heart-related conditions in companion animals and rising awareness among pet owners about the importance of early diagnosis and ongoing cardiac care. As pets live longer due to better nutrition, preventive care, and advanced medical treatments, age-related cardiovascular diseases-including congestive heart failure, arrhythmias, valve disorders, and congenital anomalies-are becoming more common. Dog breeds such as Cavalier King Charles Spaniels, Boxers, and Doberman Pinschers, as well as certain cat breeds, are genetically predisposed to heart issues, necessitating specialized care. Veterinary cardiologists and general practitioners alike are seeing a growing caseload of animals requiring diagnostics like echocardiography, electrocardiograms (ECGs), radiographic imaging, and cardiac biomarker testing. Pet owners, increasingly viewing their animals as family members, are more willing to pursue advanced diagnostic and therapeutic interventions to improve quality of life and extend longevity. This growing emphasis on animal wellness and specialized care is significantly expanding the demand for veterinary cardiology services across urban clinics, specialty hospitals, and academic veterinary centers worldwide.

How Are Innovations in Diagnostics and Imaging Enhancing Cardiac Care for Animals?

Technological innovation is reshaping veterinary cardiology, enabling earlier detection, more accurate diagnosis, and better monitoring of cardiovascular diseases in animals. Modern echocardiography machines now offer high-resolution, Doppler-based imaging tailored for veterinary use, allowing clinicians to assess blood flow, valve function, and chamber dimensions with high precision. Portable and wireless ECG systems are making it easier to perform heart rhythm analysis in clinical or even home-based settings, improving access to diagnostics in general practices and mobile services. Cardiac biomarkers such as NT-proBNP and troponin are being increasingly utilized for screening, staging, and monitoring heart disease, providing a minimally invasive complement to imaging diagnostics. Advanced imaging tools like 3D echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI) are becoming more prevalent in veterinary referral centers, especially for complex cases. Telemedicine is also playing a growing role in veterinary cardiology, enabling practitioners to consult with specialists remotely and receive rapid interpretations of ECGs or echo results. These technological developments are streamlining workflows, enhancing clinical accuracy, and ultimately contributing to more effective management and improved outcomes in veterinary cardiac patients.

Why Are Veterinary Clinics and Specialty Hospitals Expanding Cardiology Services?

Veterinary clinics, specialty hospitals, and academic centers are increasingly investing in cardiology services to meet rising demand for specialized care and to offer full-service, integrated treatment for complex cases. General veterinary practices are incorporating basic cardiac screening tools-such as auscultation training, handheld ultrasound devices, and ECGs-into wellness exams and pre-anesthetic screenings, helping to catch early signs of cardiac disease. Referral and specialty hospitals are going a step further, establishing dedicated cardiology departments with board-certified specialists and state-of-the-art diagnostic suites. These centers are not only diagnosing but also managing chronic cardiac conditions with long-term pharmacologic therapy, pacemaker implantation, fluid management protocols, and surgical interventions when needed. Academic veterinary schools are strengthening cardiology curricula and expanding research in comparative cardiology, drug development, and congenital heart defect repair. Additionally, collaboration with pharmaceutical and medical device companies is leading to the development of new treatment options tailored for small animals. Clinics offering advanced cardiac care are gaining a competitive edge by addressing a growing segment of pet healthcare that is deeply valued by pet owners and often requires repeat visits, ongoing monitoring, and personalized treatment plans-resulting in stronger client relationships and higher lifetime patient value.

What’s Driving the Global Growth of the Veterinary Cardiology Market?

The growth in the veterinary cardiology market is driven by several interrelated factors tied to pet demographics, technological progress, clinical innovation, and increasing consumer willingness to invest in advanced animal care. A significant driver is the global rise in pet ownership and the growing trend of pet humanization, which has led to greater awareness of chronic and age-related conditions like heart disease. The availability of more accurate and affordable diagnostic tools is empowering general practitioners to screen and refer patients for specialized cardiac evaluations earlier in the disease cycle. Advancements in veterinary pharmaceuticals-especially in areas like ACE inhibitors, beta blockers, diuretics, and novel heart medications-are enabling more effective long-term management of cardiac conditions. The expansion of specialty care facilities and veterinary cardiology training programs is helping to bridge the gap in specialist access, particularly in urban centers. Furthermore, the growth of pet insurance coverage is making advanced cardiac care financially accessible to a larger client base. Research collaborations and clinical trials are also accelerating drug development and treatment protocols. Together, these factors are propelling veterinary cardiology from a niche specialty to a mainstream component of comprehensive pet healthcare, with growing influence on how clinics are structured, how veterinary professionals are trained, and how pet health is managed in the years to come.

SCOPE OF STUDY:

The report analyzes the Veterinary Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Companion Animals, Production Animals); Product (Pharmaceuticals, Diagnostics); Indication (Congestive Heart Failure, Myocardial Disease, Arrhythmias, Others); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• ALBA Medical Systems, Inc.
• Antech Diagnostics
• Boehringer Ingelheim International
• Bionet America
• Ceva Sante Animale
• Cronus Pharma
• Dextronix
• Esaote SpA
• FUJIFILM Holdings Corporation
• General Electric Company
• IDEXX Laboratories
• IMV Technologies
• Infiniti Medical
• Jurox
• Medtronic
• Merck & Co., Inc.
• Patterson Veterinary
• Pet Cardiology
• RHC Medical
• Scapa Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Veterinary Cardiology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Cardiac Conditions in Aging Pets Throws the Spotlight on Specialized Veterinary Cardiology Services
  • Advancements in Diagnostic Imaging and ECG Technologies Strengthen the Business Case for Cardiology Integration
  • Increased Pet Owner Awareness of Heart Health Propels Growth in Preventive Cardiac Screening and Monitoring
  • Here's How Breed-Specific Genetic Predispositions Are Driving Adoption of Early Cardiac Evaluations
  • Expansion of Veterinary Specialty Clinics and Referral Hospitals Accelerates Demand for Cardiology Equipment
  • Integration of Telecardiology and Remote Diagnostics Expands Access to Expertise in Underserved Regions
  • Growth in Companion Animal Lifespans Sustains Long-Term Demand for Chronic Cardiac Disease Management
  • Widespread Adoption of Echocardiography and Doppler Imaging Enhances Diagnostic Accuracy and Clinical Confidence
  • Here's the Story Behind the Surge in Demand for Cardiac Medications and Evidence-Based Treatment Protocols
  • Increased Availability of Pet Insurance Encourages Pursuit of Advanced and Costlier Cardiology Procedures
  • Development of Wearable Monitoring Devices and AI Diagnostics Accelerates Innovation in Cardiac Care
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Veterinary Cardiology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Veterinary Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Production Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Production Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Production Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Congestive Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Congestive Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Congestive Heart Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Myocardial Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Myocardial Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Myocardial Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Arrhythmias by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• JAPAN
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• CHINA
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• EUROPE
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Veterinary Cardiology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• FRANCE
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• GERMANY
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 134: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 146: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Europe Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 183: Asia-Pacific Historic Review for Veterinary Cardiology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 197: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Australia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Australia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• INDIA
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 209: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: India Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: India 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 212: India Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 221: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: South Korea Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: South Korea 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 245: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Latin America Historic Review for Veterinary Cardiology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Latin America 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 260: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Argentina Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Argentina 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 272: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Brazil Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Brazil 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 284: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Mexico Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Mexico 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Latin America Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 308: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 309: Middle East Historic Review for Veterinary Cardiology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Middle East 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 323: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Iran Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Iran 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 335: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Israel Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Israel 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Saudi Arabia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 359: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: UAE Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: UAE 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Rest of Middle East Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
• AFRICA
  • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 383: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Africa Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Africa 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION